Amelioration of Central Nervous System Autoimmunity Through FFAR2 Agonism Is Associated With Changes in Gut Microbiota
The effects of Cpd1 on the gut microbiota and SCFA composition are relevant to the observed treatment benefit of FFAR2 agonism in the EAE model during the inductive phase of the disease.
Authors
- Milica Lazarević (ORCID: https://orcid.org/0000-0001-9657-2094)
- Goran Stegnjaić (ORCID: https://orcid.org/0000-0002-7658-1994)
- Djordje Miljković (ORCID: https://orcid.org/0000-0002-5613-9306)
- Suzana Stanisavljević (ORCID: https://orcid.org/0000-0003-0781-8828)
- Bojan Jevtić (ORCID: https://orcid.org/0000-0002-1076-0543)
- Mirjana Dimitrijević (ORCID: https://orcid.org/0000-0002-9094-5248)
- Graeme L. Fraser (ORCID: https://orcid.org/0000-0001-9182-5929)
- Filip Nikolić (ORCID: https://orcid.org/0009-0007-7887-6183)
Institutions
- University of Belgrade (RS)
- Bone Therapeutics (BE)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1002/brb3.70350
- Citations
- 1
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Science Fund of the Republic of Serbia